Investigating the genetic association between ERAP1 and ankylosing spondylitis.
A strong association between ERAP1 and ankylosing spondylitis (AS) was recently identified by the Wellcome Trust Case Control Consortium and the Australo-Anglo-American Spondylitis Consortium (WTCCC-TASC) study. ERAP1 is highly polymorphic with strong linkage disequilibrium evident across the gene. We therefore conducted a series of experiments to try to identify the primary genetic association(s) with ERAP1. We replicated the original associations in an independent set of 730 patients and 1021 controls, resequenced ERAP1 to define the full extent of coding polymorphisms and tested all variants in additional association studies. The genetic association with ERAP1 was independently confirmed; the strongest association was with rs30187 in the replication set (P = 3.4 x 10(-3)). When the data were combined with the original WTCCC-TASC study the strongest association was with rs27044 (P = 1.1 x 10(-9)). We identified 33 sequence polymorphisms in ERAP1, including three novel and eight known non-synonymous polymorphisms. We report several new associations between AS and polymorphisms distributed across ERAP1 from the extended case-control study, the most significant of which was with rs27434 (P = 4.7 x 10(-7)). Regression analysis failed to identify a primary association clearly; we therefore used data from HapMap to impute genotypes for an additional 205 non-coding SNPs located within and adjacent to ERAP1. A number of highly significant associations (P < 5 x 10(-9)) were identified in regulatory sequences which are good candidates for causing susceptibility to AS, possibly by regulating ERAP1 expression.
Harvey
David
D
Botnar Research Centre, Institute of Musculoskeletal Science, Oxford OX37LD, UK.
Pointon
Jennifer J
JJ
Evans
David M
DM
Karaderi
Tugce
T
Farrar
Claire
C
Appleton
Louise H
LH
Sturrock
Roger D
RD
Stone
Millicent A
MA
Oppermann
Udo
U
Brown
Matthew A
MA
Wordsworth
B Paul
BP
D000626:Aminopeptidases / Q000737:chemistry / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D016015:Logistic Models; D015778:Minor Histocompatibility Antigens; D008958:Models, Molecular; D020641:Polymorphism, Single Nucleotide; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D017422:Sequence Analysis, DNA; D013167:Spondylitis, Ankylosing / Q000235:genetics*
D015778:Minor Histocompatibility Antigens; D000626:Aminopeptidases; C464841:ERAP1 protein, human
Nat Immunol. 2002 Dec;3(12):1169-76
12436109
Immunity. 1994 Sep;1(6):491-500
7895159
Ann Rheum Dis. 2010 Apr;69(4):733-6
19433412
Nat Genet. 2007 Nov;39(11):1329-37
17952073
EMBO J. 1990 Oct;9(10):3269-78
1698610
Science. 1993 Aug 6;261(5122):769-71
8342042
J Mol Biol. 2005 Jun 17;349(4):787-800
15893768
Nat Genet. 2007 Oct;39(10):1202-7
17873877
Am J Hum Genet. 2002 Apr;70(4):845-57
11875755
Biochem Biophys Res Commun. 2008 Jul 4;371(3):505-9
18445477
J Clin Invest. 2002 Aug;110(4):515-26
12189246
Am J Hum Genet. 2001 Apr;68(4):918-26
11231900
J Biol Chem. 1999 Feb 5;274(6):3363-71
9920878
Nat Immunol. 2001 Jul;2(7):644-51
11429550
FEBS Lett. 2006 Mar 20;580(7):1833-8
16513116
Isr J Med Sci. 1992 Feb;28(2):126-30
1313788
Genome Res. 2003 Aug;13(8):1855-62
12902379
Cell. 1990 Apr 20;61(2):361-70
2158863
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17107-12
16286653
Arthritis Rheum. 1984 Apr;27(4):361-8
6231933
Mol Biol Evol. 1995 Sep;12(5):921-7
7476138
Adv Exp Med Biol. 2007;623:212-23
18380349
J Biochem. 2001 Aug;130(2):235-41
11481040
Nat Rev Genet. 2002 Apr;3(4):285-98
11967553
PLoS One. 2008;3(10):e3362
18846218
Am J Hum Genet. 2007 Sep;81(3):559-75
17701901
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9130-4
8415666
J Biol Chem. 2003 Aug 1;278(31):28677-85
12748171
Hum Mol Genet. 2005 Dec 15;14(24):3963-71
16301213
J Immunol. 2003 Dec 15;171(12):6814-9
14662887
J Biol Chem. 2006 Mar 10;281(10):6860-73
16407280
Arthritis Rheum. 2009 May;60(5):1317-23
19404951
Nat Immunol. 2002 Dec;3(12):1177-84
12436110
Mol Immunol. 2002 Oct;39(3-4):181-202
12200050